DDDD.L Share News (DDDD)
DDDD Share
DDDD Share
DDDD Share
DDDD Share
DDDD
DDDD Share
DDDD Broker
DDDD Directors
DDDD Financial
DDDD
DDDD Short
DDDDTue, 12th Jun 2018 17:55
LONDON (Alliance News) - 4d Pharma PLC said Janus Henderson Group PLC increased stake in the pharmaceutical company to 5.2% after a transaction on Tuesday.
Janus Henderson raised its holding to 3.4 million shares, equivalent to a 5.2% stake. It has not been disclosed how many shares Janus Henderson held in the company prior to the transaction.
Shares in 4d Pharma closed up 1.6% at 137.15 pence per share on Tuesday.
4D Pharma, Merck And Pfizer Ink Trial Collaboration For Carcinoma Drug
Read more
(Sharecast News) - Biotherapeutic pharmaceutical company 4D Pharma announced progress on activities in its development programme for its lead immuno-oncology single strain 'live biotherapeutic' candidate MRx0518 on Wednesday.
Read moreSMALL-CAP WINNERS & LOSERS: Dr Martens Puts Best Foot Forward
Read more4D Pharma Says MRx0518 Part B Study Enrolment Continues To Progress
Read more4D Pharma Joins Landmark Study For Parkinson's Treatment Development
Read more4D Pharma Files US Registration Statement For ADR Programme
Read moreIN BRIEF: 4d Pharma Reports Positive Data From Ongoing MRx051 Trials
Read moreIN BRIEF: 4D Pharma Proposes Merger With Longevity Acquisition
Read moreUK WINNERS & LOSERS SUMMARY: Shaftesbury Down 13% Amid Fundraise Plans
Read more4D Pharma Reports Positive Results From Bowel Syndrome Treatment Trial
Read moreIN BRIEF: 4D Pharma Interim Loss Widens On R&D Costs Increase
Read moreUK EXECUTIVE CHANGE SUMMARY: Primorus Adds Three Directors To Board
Read moreUK WINNERS & LOSERS SUMMARY: Provident Financial Up On Better Outlook
Read more4D Pharma Says Results In MRx0518, Keytruda Cancer Trial "Encouraging"
Read moreUK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech
Read more